Xencor XNCR
NASDAQ XNCR
$26.61 -0.01 (-0.04%)
As of: Sep 4, 2026 · 3:59 PM EDT

Xencor (XNCR) Net Income (2013 - 2026)

Xencor (XNCR) posted quarterly Net Income of -$128.9 million for Q1 2026, down 164.95% year-over-year from $198.5 million in Q1 2025, and down 1838.01% quarter-over-quarter from -$6.7 million in Q4 2025.

Analysis

Xencor (XNCR) Net Income (2013 - 2026) Analysis & Trends

Xencor (XNCR) has reported Net Income for 14 consecutive years, with -$128.9 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Net Income fell 164.95% year-over-year to -$128.9 million; the TTM figure through Mar 2026 stood at -$172.4 million (up 18.31% YoY), while the FY2025 annual figure was -$92.1 million, up 61.05% from the prior year.
  • Net Income declined to -$128.9 million in Q1 2026 per XNCR's latest filing, from -$6.7 million in the prior quarter.
  • Across five years, Net Income topped out at $25.8 million in Q1 2022 and bottomed at -$128.9 million in Q1 2026.
  • Historically, Net Income has averaged -$42.2 million across 5 years, with a median of -$46.2 million in 2024.
  • Annual changes were most pronounced in 2022 — Net Income jumped 259.43% — and 2023, when it slumped 327.17%.
  • Xencor's Net Income stood at -$12.0 million in 2022, then sank by 118.49% to -$26.3 million in 2023, then sank by 75.6% to -$46.2 million in 2024, then soared by 85.6% to -$6.7 million in 2025, then plunged by 1838.01% to -$128.9 million in 2026.
  • Business Quant data shows XNCR's Net Income at -$128.9 million in Q1 2026, -$6.7 million in Q4 2025, and -$6.0 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 1.10 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 1.30 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 601.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -782.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -644.37 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 237.01 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 164.49 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 81.49 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -13.27 Mn
10 Xencor 2.02 Bn 1.65 Bn - -21.72 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -21.72 Mn
Mar 31, 2026 -128.94 Mn
Dec 31, 2025 -6.65 Mn
Sep 30, 2025 -6.03 Mn
Jun 30, 2025 -30.78 Mn
Mar 31, 2025 -48.67 Mn
Dec 31, 2024 -46.20 Mn
Sep 30, 2024 -47.44 Mn
Jun 30, 2024 -68.78 Mn
Mar 31, 2024 -74.12 Mn
Dec 31, 2023 -26.31 Mn
Sep 30, 2023 -24.27 Mn
Jun 30, 2023 -26.00 Mn
Mar 31, 2023 -57.85 Mn
Dec 31, 2022 -12.06 Mn
Sep 30, 2022 -32.77 Mn
Jun 30, 2022 -28.00 Mn
Mar 31, 2022 26.47 Mn
Dec 31, 2021 73.06 Mn
Sep 30, 2021 -40.19 Mn